🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Metabolic Characterization of Space Occupying Lesions of the Brain

Recruitingn/aAges 18 Years - anyAllInsel Gruppe AG, University Hospital Bern
NCT04233788 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

High field MR-technologies are expected to boost metabolic spectroscopic imaging (MRSI), but also CEST-MRI. This is due to the fact that increased SNR is available which can be used to increase the spatial resolution of all sequences, or reduction of measurement times. Recent findings has shown that MRSI can be used to evaluate the isocitrate dehydrogenase (IDH) status of gliomas, a brain tumor type which is most often diagnosed in humans. Patients with IDH-mutated gliomas have a much longer survival time that IDH-wildtype. In IDH-mutated gliomas the substance 2-hydroxy-glutarate (2HG) is found, whereas in IDH-wildtype gliomas it is not. The underlying trial aims to measure 2HG directly with different MRSI sequences at 3 Tesla (3T) and 7 Tesla (7T) magnetic field strength. Apart from MRSI-techniques for IDH-typing it has been shown that CEST-imaging can also be performed to determine th

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Healthy people who are able to lie in the MR scanner for one hour; * Patients with suspected mass in the brain * Written informed consent Exclusion Criteria: * Persons under the age of 18 * Persons who are mentally unable to choose to participate * Pregnant women * Patients with oncological findings or neurodegenerative findings in the past * Wearing active implants (e.g. pacemakers and neurostimulators) * Emergency patients * Persons with tattoos on the head or neck area
💊

What it tests

  • MR-scans using a 3T Prisma and a 7T Terra scanner (Siemens, Erlangen Germany)
📍

Where

1 site
Institute for Diagnostic and Interventional Neuroradiology, University Hospital Bern
Bern, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy